Home Ingredients Pomella® (Pomegranate Extract — Verdure Sciences)
CardiovascularAntioxidantAnti-Inflammatory

Pomella® (Pomegranate Extract — Verdure Sciences)

Punica granatum
Evidence Level
Limited
3 Clinical Trials
6 Documented Benefits
2/5 Evidence Score

Pomella is the branded standardized pomegranate extract from Verdure Sciences (Indiana, USA), a standardized pomegranate extract, standardized to >=30% punicalagin. The cited human research on Pomella comprises two small brand-sponsored RCTs on gut-microbiome and skin endpoints, supported by in-vitro mechanistic work; cardiovascular, blood-pressure and endothelial effects reflect pomegranate polyphenols as a class and are not established by any Pomella trial cited here. The proprietary extraction process preserves the punicalagin profile in a stable, water-soluble powder suitable for capsule and beverage applications. The honest framing: the cited Pomella human trials are two small brand-sponsored RCTs on gut-microbiome and skin endpoints, with reproducible punicalagin standardization that generic pomegranate products often lack. The main documented advantage is reproducible punicalagin standardization; generic pomegranate extracts at proper punicalagin standardization deliver similar mechanism at lower cost. Pomegranate juice provides similar polyphenol content but with a sugar load.

Studied Dose Cited Pomella trials used ~250 mg/day (gut-microbiome and skin RCTs); pomegranate-extract research generally uses up to ~1,000-1,500 mg/day.
Active Compound Pomella pomegranate extract (Verdure Sciences), standardized to >=30% punicalagin.

Benefits

Standardized punicalagin delivery

Pomella® standardizes to ≥30% punicalagin — among the highest standardization in the pomegranate extract market. Punicalagin is the source compound that gut bacteria convert to bioactive urolithins. Standardization enables reproducible clinical effects.

Supported by Trial 2, Trial 1

Cardiovascular rationale (pomegranate class, not Pomella-specific trials)

Blood-pressure and endothelial effects are reported for pomegranate polyphenols as a class; the cited Pomella references studied gut-microbiome and skin endpoints (two small RCTs) plus in-vitro models, and do not include a Pomella cardiovascular trial.

Supported by Trial 1, Trial 2

Antioxidant biomarker enhancement

Antioxidant activity is documented for pomegranate polyphenols; the cited Pomella studies are a gut-microbiome RCT, a skin RCT, and in-vitro keratinocyte work rather than dedicated human antioxidant-biomarker trials of this extract.

Supported by Trial 2, Trial 1

Joint health and exercise recovery (emerging)

Joint-health and exercise-recovery uses are proposed from pomegranate polyphenol anti-inflammatory activity; no Pomella clinical trial in these areas is cited here. The polyphenol profile supports the broader anti-inflammatory positioning beyond cardiovascular applications.

Supported by Trial 3, Trial 1

Stable water-soluble format

Pomella®'s extraction process produces a stable water-soluble powder suitable for capsule and beverage applications. Stability and processing convenience supports use across various supplement formulations.

Supported by Trial 3

Quality control over generic alternatives

Generic pomegranate extracts vary significantly in actual punicalagin content (often well below labeled amounts). Pomella® addresses this through verified standardization. Quality control advantage for clinical applications.

Supported by Trial 3, Trial 1

Mechanism of action

1

Punicalagin to urolithin conversion

Pomella® punicalagin reaches the colon and is converted by gut bacteria to bioactive urolithins (primarily urolithin A). The downstream urolithin effects include mitochondrial function support and anti-inflammatory activity. Note: individual variation in this conversion exists.

2

Cardiovascular pathway support

Pomella® components support nitric oxide pathway, reduce vascular oxidative stress, and modulate inflammatory markers. These are pomegranate polyphenol class mechanisms; no cited Pomella cardiovascular trial demonstrates these outcomes.

3

Antioxidant activity

Pomella® polyphenols directly scavenge free radicals and support cellular antioxidant defenses. The unique punicalagin structure provides distinct antioxidant activity from other polyphenol sources.

Clinical trials

1
Cardiovascular rationale (pomegranate class, not Pomella trials)

No Pomella-specific cardiovascular clinical trial is cited in this record; blood-pressure and endothelial effects described here derive from pomegranate polyphenol class data, not a cited Pomella study.

Clinical population described in trial publication.

No cardiovascular Pomella trial is cited here. The cited Pomella human trials studied gut-microbiome (Sivamani 2023) and skin/wrinkle (Chakkalakal 2022) endpoints; cardiovascular effects reflect the pomegranate polyphenol class.

2
Antioxidant rationale (in-vitro and pomegranate-class data)

No dedicated Pomella antioxidant-biomarker human trial is cited; antioxidant rationale rests on in-vitro keratinocyte work (Liu 2019) and pomegranate-class data.

Clinical population described in trial publication.

No dedicated Pomella antioxidant-biomarker human trial is cited. Antioxidant rationale rests on the in-vitro keratinocyte study (Liu 2019) and pomegranate polyphenol class data, not a clinical antioxidant-capacity trial of this extract.

3
Joint health and recovery research

No Pomella joint-health or exercise-recovery clinical trial is cited; these are proposed applications from pomegranate polyphenol anti-inflammatory activity.

Clinical population described in trial publication.

No Pomella joint-health or exercise-recovery clinical trial is cited in this record; these are proposed applications based on pomegranate polyphenol anti-inflammatory activity.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated at standard doses.
Mild GI discomfort possible at higher doses in sensitive individuals.
No significant adverse events documented in clinical trial use.
Long-term safety profile reassuring through clinical trial protocols.
Pregnant women should consult healthcare providers for high-dose supplementation.

Important Drug interactions

Antihypertensive medications — may modestly enhance BP-lowering effects.
Statins (particularly rosuvastatin) — possible interactions; consult healthcare providers.
Anticoagulants — theoretical caution through mild antiplatelet effects.
ACE inhibitors — additive blood pressure-lowering possible.
Generally minimal interactions with most common medications.

More Cardiovascular Ingredients

Cardiovascular
Niacin
Niacin (vitamin B3) is an essential water-soluble vitamin central to energy metabolism, DN…
Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body and an essential min…
Cardiovascular
Phytosterols (Plant Sterols & Stanols)
Phytosterols (plant sterols and stanols) are plant-derived compounds structurally similar…
Cardiovascular
MegaNatural®-BP (Patented Grape Seed Extract — Polyphenolics)
MegaNatural-BP is a patented grape seed extract developed by Polyphenolics (division of Ca…

Explore Other Ingredients

Metabolic Health
Inulin
Inulin is a soluble prebiotic fiber found naturally in chicory root, agave, and many veget…
Antioxidant
Astaxanthin
Astaxanthin is a powerful red-orange antioxidant carotenoid best known for its anti-inflam…
Bone Health
Collagen
Collagen is the most abundant structural protein in the human body — making up roughly 30%…

Frequently asked questions about Pomella® (Pomegranate Extract — Verdure Sciences)

What is Pomella?

Pomella is the branded standardized pomegranate extract from Verdure Sciences (Indiana, USA), a standardized pomegranate extract, standardized to >=30% punicalagin.

What is Pomella used for?

Pomella is researched primarily for Cardiovascular, Antioxidant, and Anti-Inflammatory. Pomella® standardizes to ≥30% punicalagin — among the highest standardization in the pomegranate extract market. Punicalagin is the source compound that gut bacteria convert to bioactive urolithins.

What is the recommended dosage of Pomella?

The clinically studied dose is Cited Pomella trials used ~250 mg/day (gut-microbiome and skin RCTs); pomegranate-extract research generally uses up to ~1,000-1,500 mg/day. Always follow the product label and check with a healthcare provider for personal advice.

Is Pomella safe, and does it have side effects?

For most healthy adults, Pomella is well tolerated at studied doses. Reported effects can include: Generally well-tolerated at standard doses. Mild GI discomfort possible at higher doses in sensitive individuals. It may also interact with some medications. Pomella is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Pomella interact with any medications?

Possible interactions include: Antihypertensive medications — may modestly enhance BP-lowering effects. Statins (particularly rosuvastatin) — possible interactions; consult healthcare providers. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Pomella?

NutraSmarts rates the evidence for Pomella as Limited (2 out of 5). It is backed by 3 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Sivamani RK, Chakkalakal M, Pan A, Nadora D, Min M, Dumont A, Burney WA, Chambers CJ Prospective Randomized, Double-Blind, Placebo-Controlled Study of a Standardized Oral Pomegranate Extract on the Gut Microbiome and Short-Chain Fatty Acids Foods. 2023;13(1):15. doi: 10.3390/foods13010015.PubMedUsed to support: Backs the gut-microbiome/ellagitannin-conversion (urolithin precursor) effects of Pomella (punicalagin-standardized pomegranate extract, 250 mg). Randomized double-blind placebo-controlled trial; small but methodologically solid and explicitly uses Pomella.
  2. Chakkalakal M, Nadora D, Gahoonia N, Dumont A, Burney W, Pan A, Chambers CJ, Sivamani RK Prospective Randomized Double-Blind Placebo-Controlled Study of Oral Pomegranate Extract on Skin Wrinkles, Biophysical Features, and the Gut-Skin Axis J Clin Med. 2022;11(22):6724. doi: 10.3390/jcm11226724.PubMedUsed to support: Backs the skin-health/anti-aging (wrinkles, skin biophysical features, gut-skin axis) use of Pomella (Verdure Sciences). Randomized double-blind placebo-controlled study; explicitly uses Pomella, though sample size is small.
  3. Li H, Roy T, Boateng ST, He H, Liu C, Liu W, Li D, Wu P, Seeram NP, Chamcheu JC, Ma H Standardized Pomegranate (Pomella) and Red Maple (Maplifa) Extracts and Their Phenolics Protect Type I Collagen by the Inhibition of Matrix Metalloproteinases, Collagenase, and Collagen Cross-Linking Molecules. 2022;27(22):7919. doi: 10.3390/molecules27227919.PubMedUsed to support: Backs a skin/anti-aging mechanism for Pomella: inhibition of collagen-degrading matrix metalloproteinases and collagenase. In-vitro mechanistic study explicitly using Pomella; supports rationale rather than clinical outcomes.
  4. Liu C, Guo H, DaSilva NA, Li D, Zhang K, Wan Y, Gao XH, Chen HD, Seeram NP, Ma H Pomegranate (Punica granatum) Phenolics Ameliorate Hydrogen Peroxide-Induced Oxidative Stress and Cytotoxicity in Human Keratinocytes J Funct Foods. 2019;54:559-567. doi: 10.1016/j.jff.2019.02.015.PubMedUsed to support: Backs the antioxidant/skin (UV/oxidative-stress) protection rationale for Pomella: pomegranate (Pomella) phenolics reduced H2O2-induced oxidative stress and cytotoxicity in human keratinocytes. In-vitro mechanistic study using Pomella; preliminary support for skin/UV claims.